New research from UCLA links prolonged exposure to the pesticide chlorpyrifos to increased Parkinson’s risk, with supporting ...

BlueRock Therapeutics, a Bayer subsidiary developing stem cell treatments for Parkinson’s disease, has partnered with Rune ...

The ANVS-25002 study is expected to enroll approximately 500 participants with Parkinson’s disease across multiple clinical ...

A new study in the Journal of Neurology offers critical longitudinal insights into how symptoms and functional impacts evolve ...

Mission for Movement, is working to bring awareness to the disease and will host a free Parkinson's screening event on Friday ...

Parkinson’s disease — which causes poor balance and stiff movement — affects an estimated 1 million Americans. That number is expected to rise by 20% in the next few years. While there’s no sure-fire ...

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has notified manufacturers of certain ...

Objectives Parkinson’s disease (PD) is a complex, progressive neurological disorder with motor and non-motor symptoms. Among ...

Parkinson’s disease is the fastest growing neurological disorder, with over 10 million cases worldwide. Up to 150,000 Australians currently live with the disease and 50 new cases are diagnosed each ...